Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nevis Brands Inc C.NEVI

Alternate Symbol(s):  NEVIF

Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include the flagship brand Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience with no cannabis taste or smell. Major offers various flavors, such as volcanic orange mango, sunset pink lemonade, Pacific Coast blue raspberry, dreamin' of passion, and sacred grape. It also offers Major Minis, which is a smaller 2 ounce (oz) shot. Major Minis come in three flavors, such as blueberry, fruit punch, and blackberry lemonade. The Company has introduced Major Mojo-Rita and Sugar-Free Ginger-ade in Washington and Major Sugar-Free Lemonade and Apple Peach in Missouri.


CSE:NEVI - Post by User

Post by OwnerzzZon Apr 17, 2024 1:31pm
163 Views
Post# 35994176

If costs hold NEVI is $100,000+ Ebitda Qtrly at $500k revs

If costs hold NEVI is $100,000+ Ebitda Qtrly at $500k revsBasically would have been breakeven at $400,000 revenues (even w/ extra costs this quarter). Assuming costs stay same, or reduce as per guidance, would have $100,000 Ebitda per quarter at $500,000 revenues. That is very foreseeable and achievable and equates to approx. 10x cash flow valauation at $4M cap.
<< Previous
Bullboard Posts
Next >>